Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan
Clinical trial NCT03649152 · COMPLETED
Trial details
- NCT number
- NCT03649152
- Sponsor
- Dimerix Bioscience Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-08
- Primary completion
- 2020-06-16
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.